OB-GYNs in Idaho are leaving the profession after the state's new regulations. Local healthcare providers think the government's decisions are unfair. Meanwhile, the company announced a dividend boost but changed its production outlook. Dr. Reddy's launched generic alternatives to Ozempic. Medicaid patients are seeing a drop in menopause visits.